Dimitrios Moianos

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Trypanosoma Cruzi

Top Venues

Pharmaceuticals (Basel, Switzerland)

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Dimitrios Moianos, Maria Makri, Georgia-Myrto Prifti, Aristeidis Chiotellis, Alexandros Pappas, Molly E Woodson, Razia Tajwar, John E Tavis, Grigoris Zoidis
N -Hydroxypiridinedione: A Privileged Heterocycle for Targeting the HBV RNase H. Molecules (Basel, Switzerland) 29 (12) (2024)
Dimitrios Moianos, Maria Makri, Georgia-Myrto Prifti, Aristeidis Chiotellis, Alexandros Pappas, Molly E Woodson, Razia Tajwar, John E Tavis, Grigoris Zoidis
N -Hydroxypiridinedione: A Privileged Heterocycle for Targeting the HBV RNase H. Molecules (Basel, Switzerland) 29 (12) (2024)
Dimitrios Moianos, Maria Makri, Georgia-Myrto Prifti, Aristeidis Chiotellis, Alexandros Pappas, Molly E Woodson, Razia Tajwar, John E Tavis, Grigoris Zoidis
N -Hydroxypiridinedione: A Privileged Heterocycle for Targeting the HBV RNase H. Molecules (Basel, Switzerland) 29 (12) (2024)
Dimitrios Moianos, Georgia-Myrto Prifti, Maria Makri, Grigoris Zoidis
Targeting Metalloenzymes: The "Achilles' Heel" of Viruses and Parasites. Pharmaceuticals (Basel, Switzerland) 16 (6) (2023)
Dimitrios Moianos, Georgia-Myrto Prifti, Maria Makri, Grigoris Zoidis
Targeting Metalloenzymes: The "Achilles' Heel" of Viruses and Parasites. Pharmaceuticals (Basel, Switzerland) 16 (6) (2023)
Georgia-Myrto Prifti, Dimitrios Moianos, Erofili Giannakopoulou, Vasiliki Pardali, John E Tavis, Grigoris Zoidis
Recent Advances in Hepatitis B Treatment. Pharmaceuticals (Basel, Switzerland) 14 (5) (2021)